The ENPP1 K121Q polymorphism is not associated with type 2 diabetes and related metabolic traits in an Iranian population.

Saberi, Hamzeh; Mohammadtaghvaei, Narges; Gulkho, Shekufeh; Bakhtiyari, Salar; Mohammadi, Mohammad; Hanachi, Parichehr; Gerayesh-nejad, Siavash; Zargari, Mehryar; Ataei, Farangis; Parvaneh, Leila; Larijani, Bagher; Meshkani, Reza

The K121Q polymorphism of the ectoenzyme nucleotide pyrophosphate phosphodiesterase 1 (ENPP1) gene has been variably associated with insulin resistance and type 2 diabetes (T2D) in several populations. However, this association has not been studied in Iranian subjects and we hypothesized that the K121Q variant might be associated with T2D and related metabolic traits in this population. The K121Q genotypes were determined by PCR-restriction fragment length polymorphism in 377 normoglycemic controls and 155 T2D patients. T2D patients had significantly higher values for systolic and diastolic blood pressure, BMI, glucose, cholesterol, triglyceride, LDL, apoB, insulin, and HOMA-IR, and lower levels of HDL than the normoglycemic subjects. The frequency of the Q allele did not differ between T2D and normoglycemic subjects (OR 0.96, 95% CI 0.90-2.00, P = 0.70). The Q allele frequency was 16.5% in T2D and 15.2% in normoglycemic subjects. The ENPP1 genotype (KQ + QQ) was not associated with the systolic and diastolic blood pressure, glucose, triglyceride, cholesterol, LDL-C and HDL-C, apo B, BMI, HOMA-IR, and insulin levels in both normoglycemic and T2D groups. Our results suggest that the ENPP1 121Q allele might not be associated with T2D and related metabolic traits among Iranian subjects.

GENETIC polymorphisms; DIABETES; PROINSULIN; CHOLESTEROL; GENETIC research; ENDOCRINE diseases

Molecular & Cellular Biochemistry, 2011, Vol 350, Issue 1/2, p113

0300-8177

Academic Journal

10.1007/s11010-010-0687-z